CC-223

CC-223

【产品别名】CC 223, CC223

【CAS号】 1228013-30-6

【目录编号】

【纯度】 >98%

【分子式】 C21H27N5O3

【分子量】 397.47

【简介】 CC-223 is a potent mTOR kinase inhibitor (IC50=16 nM), with >150-fold sensitivity over the related lipid kinase PI3Kα (IC50=4 μM).

联系我们 索取资料

CC-223 详细介绍

CC-223 is a potent mTOR kinase inhibitor (IC50=16 nM), with >150-fold sensitivity over the related lipid kinase PI3Kα (IC50=4 μM).
IC50 value:16 nM [2]
Target: mTOR
in vitro: CC-223 is a potent, selective, and orally bioavailable inhibitor of mTOR kinase, demonstrating inhibition of mTORC1 (pS6RP and p4EBP1) and mTORC2 [pAKT(S473)] in cellular systems. CC-223 competitively  inhibits  the mTOR kinase that targets mTORC1 and mTORC2, prevents upregulation of AKT phosphorylation, differentiating it from the rapalogs.
in vivo: Treatment with CC-223 afforded in vivo tumor biomarker inhibition in tumor-bearing mice, after a single oral dose. CC-223 exhibited dose-dependent tumor growth inhibition in multiple solid tumor xenografts. CC-223 is active against many non-Hodgkin lymphoma cell lines and solid tumor lines, including breast, glioma, hepatocellular carcinoma (HCC), and non-small cell lung cancer. CC-223 has demonstrated single-agent activity in several human tumor xenograft models, including U87 glioblastoma multiforme and PC3 prostate cancer. CC-223 is tolerable, with manageable toxicities. [1] CC-223, with superior physicochem-ical and pharmacokinetic properties, excellent kinase selectivity, demonstrates efficacy across multiple solid tumor models with oral dosing.

Back to top